Erudio Healtherudio.com
Drug
Encorafenib trials: what clinicians said in public
HCP commentary reports on 2 clinical trials studying encorafenib: BRICKET and ECLYPse. Each covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 9 more trials with public commentary and no report yet.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| ECLYPse NCT06640166 · Fondazione Policlinico Universitario Agostino Gemelli IRCCS | BRAF V600E-mutated metastatic colorectal cancer | Phase 2 | 23 | 8 | Focused | Nov 2, 2026 | Preview |
| BRICKET NCT06578559 · Gruppo Oncologico del Nord-Ovest | BRAF V600E-mutated metastatic colorectal cancer | Phase 2 | 21 | 12 | Focused | Oct 28, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| BREAKWATER NCT04607421 · Pfizer DeepView → | first-line BRAF V600E-mutant metastatic colorectal cancer | Phase 3 | Deep | View | |||
| PHAROS NCT03915951 · Pfizer DeepView → | BRAF V600E-mutant metastatic non-small cell lung cancer | Phase 2 | Deep | View | |||
| BEACON CRC NCT02928224 · Pfizer DeepView → | BRAF V600E-mutant metastatic colorectal cancer | Phase 3 | Deep | View | |||
| ENCO-BRAF NCT04526782 · Intergroupe Francophone de Cancerologie Thoracique DeepView → | BRAF V600E-mutant metastatic non-small cell lung cancer | Phase 2 | Deep | View | |||
| SWOG 2107 NCT05308446 · National Cancer Institute (NCI) StandardView → | previously treated microsatellite stable BRAFV600E metastatic colorectal cancer | Phase 2 | Standard | View | |||
| ANCHOR CRC NCT03693170 · Pierre Fabre Medicament StandardView → | previously untreated BRAF V600E-mutant metastatic colorectal cancer | Phase 2 | Standard | View | |||
| HERKULES-3 NCT05039177 · Erasca, Inc. FocusedView → | metastatic colorectal cancer or pancreatic ductal adenocarcinoma | Phase 1/Phase 2 | Focused | View | |||
| SEAMARK NCT05217446 · Pfizer FocusedView → | first-line BRAF V600E-mutant MSI-H/dMMR metastatic colorectal cancer | Phase 2 | Focused | View | |||
| A022004 NCT05710406 · Alliance for Clinical Trials in Oncology FocusedView → | stage II/III BRAF V600E colon cancer | Phase 2/Phase 3 | Focused | View | |||